Form SCHEDULE 13G/A XBiotech Inc. Filed by: SIMARD JOHN

January 23, 2026 2:07 PM UTC





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) This amount includes (i) 3,823,166 shares of common stock held by the Reporting Person, (ii) 1,896,609 shares of common stock issuable upon the exercise of stock options that are immediately exercisable within 60 days of December 31, 2025 held by the Reporting Person. (2) The percentage is calculated based upon a denominator that includes (i) 30,487,731 shares outstanding as of December 31, 2025 and (ii) 1,896,609 shares that are issuable upon the exercise of stock options by the Reporting Person.


SCHEDULE 13G



 
John Simard
 
Signature:/s/ John Simard
Name/Title:John Simard/Chairman of the Board of Directors, XBiotech Inc.
Date:01/23/2026


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G